Sep 19, 2020 9:22 PM
BACK TO TOP
KSE100
42,504.76
170.00
(0.40%)
ALLSHR
30,167.00
101.78
(0.34%)
KSE30
18,046.26
102.45
(0.57%)
KMI30
68,332.95
433.92
(0.64%)
BKTi
12,780.93
119.24
(0.94%)
OGTi
14,427.70
219.07
(1.54%)
KMIALLSHR
21,181.27
108.91
(0.52%)
UPP9
12,043.55
56.51
(0.47%)
NITPGI
9,217.48
69.03
(0.75%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.183.57
0.14
(0.08%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Sep 18, 2020 4:38 PM
REG
FUT
ODL
Open
184.00
High
185.00
Low
182.75
Volume
168,600
CIRCUIT BREAKER
169.67 — 197.19
DAY RANGE
182.75 — 185.00
52-WEEK RANGE
87.00 — 203.80
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
183.43
VAR
11.50
HAIRCUT
15.00
P/E Ratio (TTM)
17.12
1-Year Change *
110.95%
YTD Change *
14.32%
Open
0.00
High
0.00
Low
0.00
Close
183.13
Change
0.00%
LDCP
183.43
Volume
3
Total Trades
3
CIRCUIT BREAKER
165.09 — 201.77
DAY RANGE
0.00 — 0.00
Ask Price
186.20
Ask Volume
10
Bid Price
182.00
Bid Volume
11
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited (the Company) is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK.

KEY PEOPLE
Mr.Dmytro OliinykChairman
Ms. Erum Shakir RahimCEO
Mr. Syed Azeem Abbas NaqviCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.gsk.com.pk

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Deloitte Yousuf Adil & Co. Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
58,461,038.22
Shares
318,467,278
Free Float
51,760,668
Free Float
16.25%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Aug 31, 2020Transmission of Quarterly Report for the Period Ended 2020-06-30 View   PDF
Aug 24, 2020Financial Results for the Quarter ended June 30, 2020 View   PDF
May 28, 2020Transmission of Quarterly Report for the Period Ended 2020-03-31 View   PDF
May 15, 2020Financial Results for the Quarter ended March 31, 2020 View   PDF
Apr 29, 2020Transmission of Annual Report for the Year Ended 2019-12-31 View   PDF
Apr 16, 2020GRANT OF EXTENSION FOR FILLING OF FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2020 (Q-1) View   PDF
Mar 11, 2020financial Results for the Year Ended December 31, 2019 View   PDF
Oct 30, 2019Transmission of Quarterly Report for the Period Ended September 30, 2019 View   PDF
Oct 28, 2019Financial Results for the Quarter Ended 2019-09-30 View   PDF
Aug 29, 2019Transmission of Quarterly Report for the Period Ended June 30, 2019 View   PDF
DateTitleDocument
Aug 17, 2020Board of Directors Meeting View   PDF
May 8, 2020Board of Directors Meeting View   PDF
Apr 29, 2020Notice of Annual General Meeting View   PDF
Apr 27, 2020Notice of the Annual General Meeting prior to its publication in the newspapers View   PDF
Mar 11, 2020Board Meeting - Number of Directors View   PDF
Mar 4, 2020Board of Directors Meeting GSK Pakistan Limited View   PDF
Feb 19, 2020Emergent Board Meeting View   PDF
Oct 21, 2019Board Meeting View   PDF
Aug 21, 2019Board of Directors Meeting View   PDF
Jun 19, 2019Board Meeting Other Than Financial Results View   PDF
DateTitleDocument
Jun 15, 2020PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View   PDF
Jun 12, 2020PRIOR PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View   PDF
May 21, 2020CERTIFIED TRUE COPY OF RESOLUTION View   PDF
May 19, 2020Material Information View   PDF
May 14, 2020Notice of Election of Directors of GlaxoSmithKline Pakistan Limited published in Newspapers. View   PDF
May 13, 2020Prior Publication Notice of Election of Directors View   PDF
Apr 2, 2020Change of Non-Executive Director View   PDF
Mar 26, 2020GLAXO | GlaxoSmithKline Pakistan Limited -Notice of Postponement of AGM PDF
Mar 2, 2020Change of Chief Executive/Director View   PDF
Feb 20, 2020Material Information - GlaxoSmithKline Pakistan Limited View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2019201820172016
Sales36,581,74934,006,84032,773,77027,563,533
Profit after Taxation3,041,1233,257,9512,981,0232,762,185
EPS9.5510.239.368.68
Q2 2020Q1 2020Q3 2019Q2 2019
Sales7,738,3938,033,9168,171,4409,285,424
Profit after Taxation817,784425,564923,761341,678
EPS2.571.342.901.07
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2019201820172016
Gross Profit Margin (%)21.0824.7426.4827.08
Net Profit Margin (%)8.319.589.1010.02
EPS Growth (%)(6.65)9.297.834.58
PEG(2.53)1.192.295.87

Payouts

DateFinancial ResultsDetailsBook Closure
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 15/05/2020 - 21/05/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014
February 18, 2013 2:37 PM31/12/2012(YR) 40% (F) (D) - 10% (B) 12/04/2013 - 18/04/2013

Financial Reports